Homoeopathic treatment of asthma - a clinical trial

Efficacy of Homoeopathic Medicine in Patients Suffering from Bronchial Asthma in Adults

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009192

Enrollment

140

Registered

2017-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Bronchial asthma

Interventions

Intervention1: Conventional care (i.e. standard therapy) plus individualized homoeopathic medicines: Conventional care for bronchial asthma, e.g. beta agonists, corticosteroids, antihistamines, montel

indistinguishable from verum. To be taken thrice a day orally on clean tongue in empty stomach. Duration of therapy: 6 months

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of persistent bronchial asthma â?? mild to moderate, typical regular asthmatic attacks and illness persisting for 1 year or longer 2.Age 18-65 years 3.Both sexes 4.Ability to read Hindi and written consent to participate

Exclusion criteria

Exclusion criteria: 1.Unwillingness to participate or to comply with trial requirements 2.Too unwell to take part 3.Refused informed consent 4.RTI within last 3 weeks 5.Other diseases causing pulmonary obstruction 6.Other uncontrolled pulmonary or systemic diseases and/or pathologies 7.Psychiatric illness 8.Pregnancy or lactation 9.Previous immunotherapy 10.Ongoing use of homoeopathic remedies for any chronic purpose 11.Any change in concurrent medication in the two weeks before entry 12.Drug or substance abuse and/or dependence

Design outcomes

Primary

Measure	Time frame
Spirometer readings (FEV1, FVC, FEV1/FVC, FEF, and PEF) and blood eosinophil % and IgE levelsTimepoint: Baseline, 3 months, 6 months	—

Secondary

Measure	Time frame
1.No. of asthmatic attacks last week 2.Days of suffering last week 3.Avg. sleep interference and night awakening in hours/day last week 4.Bronchodilator use last week 5.Patient assessed severity on 0-10 point numeric rating scale (NRS) 6.Patient rated global outcome 0-10 point NRS 7.Juniperâ??s Asthma Control Questionnaire (ACQ) 8.Asthma Control Test (ACT) QuestionnaireTimepoint: Baseline, 3 months, 6 months	—

Measure

Time frame

1.No. of asthmatic attacks last week 2.Days of suffering last week 3.Avg. sleep interference and night awakening in hours/day last week 4.Bronchodilator use last week 5.Patient assessed severity on 0-10 point numeric rating scale (NRS) 6.Patient rated global outcome 0-10 point NRS 7.Juniperâ??s Asthma Control Questionnaire (ACQ) 8.Asthma Control Test (ACT) QuestionnaireTimepoint: Baseline, 3 months, 6 months

—

Countries

India

Contacts

Public ContactSubhranil Saha

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

drsubhranilsaha@hotmail.com9836187425

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026